Cathie Wood's ARK Bets Bigger On This Biotech Play, Slashes Stake In This Space Stock

• The firm has been steadily adding NTLA stock across its ETFs throughout 2026, with repeated purchases in January, February, March, and now April.
• RKLB stock’s sale marks ARK’s second offload this month.

Cathie Wood’s ARK exchange-traded funds filed two big bets on Monday, loading up on Intellia Therapeutics (NTLA), which is up more than 41% this year, while selling shares of Rocket Lab (RKLB).

ARK Investment Management bought shares in Intellia Therapeutics, potentially worth more than $3.5 million, through its ARK Innovation ETF (ARKK) and ARK Genomic Revolution ETF (ARKG), acquiring a total of more than 263,848 shares, according to Investing.com.

Meanwhile, the investment management firm’s largest trade of the day was the sale of 50,312 shares of Rocket Lab through the ARK Autonomous Technology & Robotics ETF (ARKQ), potentially totaling more than $4 million.

ARK’s Consistent Confidence In Intellia

ARK’s latest investment in the gene-editing company reinforces its confidence in it as an innovative healthcare solutions company in the biotechnology sector, rather than a one-time bet. The firm has been steadily adding NTLA stock across its ETFs throughout 2026, with repeated purchases in January, February, March, and now April.

Intellia Therapeutics is a gene-editing company focused on developing CRISPR/Cas9-based therapeutics. On Monday, the company reported positive Phase 3 trial results for lonvoculin ziclumeran (lonvo-z) for the treatment of hereditary angioedema (HAE), a rare genetic condition.

The company has also said that it has initiated a rolling Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) for approval, and is preparing for a potential U.S. launch of lonvo-z in the first half of 2027.

Rocket Lab Offload

Meanwhile, RKLB stock’s sale marks the firm’s second offload this month, even as the company’s shares have surged more than 262% in the last year, suggesting that the investment firm may be locking in gains after the rally.

The space launch company specializes in small satellite launch services for commercial and government customers. Rocket Lab completed multiple Electron missions earlier this month, including its 8th launch of the year and 87th overall, reinforcing its position in the small-satellite launch market. The company also has a pipeline of upcoming missions backed by a growing backlog.

What Retail Traders Feel About NTLA, RKLB

On Stocktwits, retail sentiment around NTLA stock was in the ‘extremely bullish’ territory amid ‘extremely high’ message volumes at the time of writing. For RKLB stock, retail sentiment was in the ‘bullish’ territory amid ‘normal’ message volumes.

Meanwhile, for the ARKK and ARKQ ETFs, retail sentiment was in the ‘bearish’ territory at the time of writing, while for the ARKG ETF, it was in the ‘neutral’ territory.

ARKK, ARKQ, and ARKG have gained more than 49%, 85%, and 33% in the last year, respectively.

For updates and corrections, email newsroom[at]stocktwits[dot]com.